BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 16849755)

  • 21. Causes of the first AIDS-defining illness and subsequent survival before and after the advent of combined antiretroviral therapy.
    Grabar S; Lanoy E; Allavena C; Mary-Krause M; Bentata M; Fischer P; Mahamat A; Rabaud C; Costagliola D;
    HIV Med; 2008 Apr; 9(4):246-56. PubMed ID: 18366449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Triple-class antiretroviral drug resistance: risk and predictors among HIV-1-infected patients.
    Napravnik S; Keys JR; Quinlivan EB; Wohl DA; Mikeal OV; Eron JJ
    AIDS; 2007 Apr; 21(7):825-34. PubMed ID: 17415037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Diagnosis and treatment of HIV-related Kaposi's sarcoma].
    Reyners AK; Sprenger HG; Suurmeijer AJ; van der Graaf WT
    Ned Tijdschr Geneeskd; 2006 Mar; 150(11):589-93. PubMed ID: 16610494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of highly active antiretroviral therapy on the presenting features and outcome of patients with acquired immunodeficiency syndrome-related Kaposi sarcoma.
    Nasti G; Martellotta F; Berretta M; Mena M; Fasan M; Di Perri G; Talamini R; Pagano G; Montroni M; Cinelli R; Vaccher E; D'Arminio Monforte A; Tirelli U; ;
    Cancer; 2003 Dec; 98(11):2440-6. PubMed ID: 14635079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natural killer cells are not infected by Kaposi's sarcoma-associated herpesvirus in vivo, and natural killer cell counts do not correlate with the risk of developing Kaposi's sarcoma.
    Stebbing J; Gazzard B; Flore O; Thomas C; Benlahrech A; Mandalia S; Bower M; Gotch F; Patterson S
    AIDS; 2003 Sep; 17(13):1998-2000. PubMed ID: 12960839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy.
    Lortholary O; Poizat G; Zeller V; Neuville S; Boibieux A; Alvarez M; Dellamonica P; Botterel F; Dromer F; Chêne G
    AIDS; 2006 Nov; 20(17):2183-91. PubMed ID: 17086058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary varicella and herpes zoster among HIV-infected children from 1989 to 2006.
    Wood SM; Shah SS; Steenhoff AP; Rutstein RM
    Pediatrics; 2008 Jan; 121(1):e150-6. PubMed ID: 18086820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era.
    El Amari EB; Toutous-Trellu L; Gayet-Ageron A; Baumann M; Cathomas G; Steffen I; Erb P; Mueller NJ; Furrer H; Cavassini M; Vernazza P; Hirsch HH; Bernasconi E; Hirschel B;
    AIDS; 2008 May; 22(9):1019-28. PubMed ID: 18520345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Timing of highly active antiretroviral therapy and chemotherapy for Kaposi's sarcoma in patients with HIV infection.
    Loke WC; Spittle MF; Mitchell S; Kulasegaram R
    Int J STD AIDS; 2006 Aug; 17(8):565-6. PubMed ID: 16925908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma.
    Bower M; Weir J; Francis N; Newsom-Davis T; Powles S; Crook T; Boffito M; Gazzard B; Nelson M
    AIDS; 2009 Aug; 23(13):1701-6. PubMed ID: 19550283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kaposi's sarcoma in a hospital setting in Lomé (Togo): a study of 93 cases.
    Pitche PT; Kombate K; Owono F; Tchangai-Walla K
    Int J Dermatol; 2007 Oct; 46 Suppl 1():42-4. PubMed ID: 17919207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV-associated Isospora belli infection: incidence and risk factors in the French Hospital Database on HIV.
    Guiguet M; Furco A; Tattevin P; Costagliola D; Molina JM;
    HIV Med; 2007 Mar; 8(2):124-30. PubMed ID: 17352769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study.
    Khanna N; Elzi L; Mueller NJ; Garzoni C; Cavassini M; Fux CA; Vernazza P; Bernasconi E; Battegay M; Hirsch HH;
    Clin Infect Dis; 2009 May; 48(10):1459-66. PubMed ID: 19348592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [AIDS-associated Kaposi's sarcoma: 22 cases].
    Dhrif AS; Kilani B; Ammari L; Kanoun F; Tiouri H; Ben Chaaben T
    Tunis Med; 2007 Jun; 85(6):494-9. PubMed ID: 17644904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of boosted protease inhibitors reduces Kaposi sarcoma incidence among male veterans with HIV infection.
    Kowalkowski MA; Kramer JR; Richardson PR; Suteria I; Chiao EY
    Clin Infect Dis; 2015 May; 60(9):1405-14. PubMed ID: 25586682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two-year outcomes of children on non-nucleoside reverse transcriptase inhibitor and protease inhibitor regimens in a South African pediatric antiretroviral program.
    Jaspan HB; Berrisford AE; Boulle AM
    Pediatr Infect Dis J; 2008 Nov; 27(11):993-8. PubMed ID: 18818556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns, predictors, and consequences of initial regimen type among HIV-infected women receiving highly active antiretroviral therapy.
    Golub ET; Benning L; Sharma A; Gandhi M; Cohen MH; Young M; Gange SJ
    Clin Infect Dis; 2008 Jan; 46(2):305-12. PubMed ID: 18171267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study.
    Simcock M; Blasko M; Karrer U; Bertisch B; Pless M; Blumer L; Vora S; Robinson JO; Bernasconi E; Terziroli B; Moirandat-Rytz S; Furrer H; Hirschel B; Vernazza P; Sendi P; Rickenbach M; Bucher HC; Battegay M; Koller MT;
    Antivir Ther; 2007; 12(6):931-9. PubMed ID: 17926647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An evaluation of the early effects of a combination antiretroviral therapy programme on the management of AIDS-associated Kaposi's sarcoma in KwaZulu-Natal, South Africa.
    Mosam A; Uldrick TS; Shaik F; Carrara H; Aboobaker J; Coovadia H
    Int J STD AIDS; 2011 Nov; 22(11):671-3. PubMed ID: 22096054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of antiretroviral therapy on oxidative stress and cardiovascular risk: a prospective cross-sectional study in HIV-infected patients.
    Masiá M; Padilla S; Bernal E; Almenar MV; Molina J; Hernández I; Graells ML; Gutiérrez F
    Clin Ther; 2007 Jul; 29(7):1448-55. PubMed ID: 17825696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.